Premium
Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency
Author(s) -
Fahey Jed W.,
Wade Kristina L.,
Wehage Scott L.,
Holtzclaw Walter David,
Liu Hua,
Talalay Paul,
Fuchs Edward,
Stephenson Katherine K.
Publication year - 2017
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201600766
Subject(s) - sulforaphane , phytochemical , bioavailability , isothiocyanate , chemistry , pharmacology , medicine , biochemistry
Scope The isothiocyanate sulforaphane (SF) from broccoli is one of the most potent known inducers of the cytoprotective phase 2 response. Its role in a host of biochemical pathways makes it a major component of plant‐based protective strategies for enhancing healthspan. Many nutritional supplements are now marketed that purport to contain SF, which in plants exists as a stable precursor, a thioglucoside hydroxysulfate. However, SF in pure form must be stabilized for use in supplements. Methods and results We evaluated the stability and bioavailability of two stabilized SF preparations—an α‐cyclodextrin inclusion (SF‐αCD), and an SF‐rich, commercial nutritional supplement. SF‐αCD area‐under‐the‐curve peak serum concentrations occurred at 2 h, but six of ten volunteers complained of mild stomach upset. After topical application it was not effective in upregulating cytoprotective enzymes in the skin of SKH1 mice whereas pure SF was effective in doing so. Both of these “stabilized” SF preparations were as potent as pure SF in inducing the cytoprotective response in cultured cells, and they were more stable and as bioavailable. Conclusion Our studies of a stabilized phytochemical component of foods should encourage further examination of similar products for their utility in chronic disease prevention and therapy.